SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
74.10
0.00 (0.00%)
Aug 18, 2026, 1:30 PM CST
SYN-TECH Chem. & Pharm. Market Cap
SYN-TECH Chem. & Pharm. has a market cap or net worth of 3.3 billion as of August 18, 2026. Its market cap has increased by 0.68% in one year.
Market Cap
3.30B
Enterprise Value
2.37B
Revenue
1.27B
Ranking
n/a
PE Ratio
10.00
Stock Price
74.10
ChartMarket Cap Chart
Since October 26, 2004, SYN-TECH Chem. & Pharm.'s market cap has increased from 412.78M to 3.30B, an increase of 700.48%. That is a compound annual growth rate of 10.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 3.30B | 0.41% |
| Dec 31, 2025 | 3.29B | -21.66% |
| Dec 31, 2024 | 4.20B | 10.56% |
| Dec 29, 2023 | 3.80B | 1.19% |
| Dec 30, 2022 | 3.75B | 43.53% |
| Dec 30, 2021 | 2.62B | 12.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.47B |
| Senhwa Biosciences | 3.47B |
| OBI Pharma | 3.47B |
| Sagittarius Life Science | 3.31B |
| BioGend Therapeutics | 3.14B |
| Shine-On BioMedical | 3.13B |
| Apex Biotechnology | 3.08B |
| Great Novel Therapeutics Biotech & Medicals | 3.06B |